Listed

Nutex Health Inc.: Form 10-K for the period ended Dec 31, 2015

Filed with the SEC on Apr 14, 2016 and accepted by EDGAR at Apr 14, 2016, 17:19 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2015-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2015-01-01 to 2015-12-31$474.7kus-gaap:SalesRevenueNet
Cost of revenue12 months2015-01-01 to 2015-12-31$8.1kus-gaap:CostOfRevenue
Gross profit12 months2015-01-01 to 2015-12-31$466.6kus-gaap:GrossProfit
Operating income12 months2015-01-01 to 2015-12-31−$499.0kus-gaap:OperatingIncomeLoss
Interest expense12 months2015-01-01 to 2015-12-31−$44.6kus-gaap:InterestExpense
Net income12 months2015-01-01 to 2015-12-31$83.8kus-gaap:NetIncomeLoss
Diluted EPS12 months2015-01-01 to 2015-12-31$0.00us-gaap:EarningsPerShareBasicAndDiluted
Diluted shares (weighted)12 months2015-01-01 to 2015-12-3129,168,374 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2015-01-01 to 2015-12-31$44.9kus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2015-01-01 to 2015-12-31−$1.8kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2015-12-31$132.0kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2015-12-31$890.7kus-gaap:AssetsCurrent
Total assetsAt period end2015-12-31$7.4mus-gaap:Assets
Current liabilitiesAt period end2015-12-31$2.9mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2015-12-31$6.1mus-gaap:Liabilities

Source: SEC EDGAR, the filing index for accession 0001211524-16-000203. Last ingested by Listed: Nov 14, 2026, 12:46 ET. Listed shows no prices and gives no investment advice.